| |
| |
|
| Insider
Information: |
Molineaux Susan |
| Relationship: |
Director |
| City: |
Menlo Park |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
14,552 |
|
|
Indirect Shares
|
204,875 |
|
|
| Direct
Value |
$92,281 |
|
|
|
Indirect Value
|
$883,178 |
|
|
| Total
Shares |
219,427 |
|
|
| Total
Value |
$975,459 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -80.3%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Geron Corporation |
GERN |
Director |
2023-05-01 |
0 |
2023-12-29 |
130,527 |
Premium* |
|
|
Calithera Biosciences, Inc. |
CALA |
PRESIDENT & CEO, Direc... |
2023-01-23 |
4,724 |
2023-01-23 |
33,142 |
Premium* |
|
|
Theravance Biopharma, Inc. |
TBPH |
Director |
2021-04-27 |
9,828 |
2021-04-27 |
41,206 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
47 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GERN |
Geron Corporation |
Director |
– • – |
2013-09-30 |
4 |
A |
$0.00 |
$0 |
I/I |
3,918 |
3,918 |
0 |
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2013-12-31 |
4 |
A |
$0.00 |
$0 |
I/I |
2,769 |
6,687 |
0 |
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2014-03-31 |
4 |
A |
$0.00 |
$0 |
I/I |
6,280 |
12,967 |
0 |
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2014-06-30 |
4 |
A |
$0.00 |
$0 |
I/I |
4,089 |
17,056 |
0 |
- |
|
| CALA |
Calithera Biosciences, In... |
PRESIDENT AND CEOOfficer |
• • – |
2014-10-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
11,000 |
|
- |
|
| CALA |
Calithera Biosciences, In... |
PRESIDENT AND CEOOfficer |
• • – |
2014-10-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
106,962 |
|
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2014-12-31 |
4 |
A |
$0.00 |
$0 |
I/I |
4,038 |
21,094 |
0 |
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2015-03-31 |
4 |
A |
$0.00 |
$0 |
I/I |
3,481 |
24,575 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Director |
– • – |
2015-04-22 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
6,000 |
0 |
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2015-06-30 |
4 |
A |
$0.00 |
$0 |
I/I |
3,067 |
27,642 |
0 |
- |
|
| CALA |
Calithera Biosciences, In... |
PRESIDENT AND CEO |
• • – |
2015-07-13 |
4 |
OE |
$0.48 |
$109,890 |
D/D |
76,287 |
78,787 |
0 |
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2015-09-30 |
4 |
A |
$0.00 |
$0 |
I/I |
4,755 |
32,397 |
0 |
- |
|
| CALA |
Calithera Biosciences, In... |
PRESIDENT AND CEO |
• • – |
2015-12-21 |
4 |
OE |
$0.48 |
$41,525 |
D/D |
27,825 |
109,112 |
0 |
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2015-12-31 |
4 |
A |
$0.00 |
$0 |
I/I |
2,712 |
35,109 |
0 |
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2016-03-31 |
4 |
A |
$0.00 |
$0 |
I/I |
4,495 |
39,604 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Director |
– • – |
2016-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
6,000 |
0 |
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2016-06-30 |
4 |
A |
$0.00 |
$0 |
I/I |
4,897 |
44,501 |
0 |
- |
|
| CALA |
Calithera Biosciences, In... |
PRESIDENT AND CEO |
• • – |
2016-07-20 |
4 |
OE |
$0.48 |
$53,218 |
D/D |
29,385 |
31,885 |
0 |
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2016-09-30 |
4 |
A |
$0.00 |
$0 |
I/I |
5,808 |
50,309 |
0 |
- |
|
| CALA |
Calithera Biosciences, In... |
PRESIDENT AND CEO |
• • – |
2016-12-19 |
4 |
OE |
$0.96 |
$47,309 |
D/D |
21,933 |
23,810 |
0 |
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2016-12-30 |
4 |
A |
$0.00 |
$0 |
I/I |
6,341 |
56,650 |
0 |
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2017-03-31 |
4 |
A |
$0.00 |
$0 |
I/I |
5,782 |
62,432 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Director |
– • – |
2017-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
12,000 |
0 |
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2017-06-30 |
4 |
A |
$0.00 |
$0 |
I/I |
4,738 |
67,170 |
0 |
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2017-09-29 |
4 |
A |
$0.00 |
$0 |
I/I |
6,021 |
73,191 |
0 |
- |
|
47 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
